SUMMARY Granulocyte lysosomal enzymes can potentially participate in cartilage degradation in inflammatory arthritides. However, we have previously shown that the quantity of several such enzymes in an inflammatory synovial effusion correlates negatively with the degree of radiographic damage of the joint from which the fluid was sampled. In the current work the quantity of the following 5 protease inhibitors was determined immunochemically in the same fluids: al antitrypsin, aoc-antichymotrypsin, M2-macroglobulin, inter-a-trypsin inhibitor, and Cl esterase inhibitor. These inhibitors are generally covariate and correlate positively with the total protein in the fluid as well as the number of granulocytes and the concentration of granulocyte lysosomal enzymes in the fluid. As did the lysosomal enzymes, the protease inhibitors correlate negatively with radiographic destruction. It is likely that lysosomal enzymes in solution in inflammatory synovial effusions are rendered effete by the presence of protease inhibitors.
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One theory of the pathogenesis of articular destruction in rheumatoid arthritis holds that polymorphonuclear neutrophil (PML) lysosomal enzymes in solution in the inflammatory synovial fluid are primarily responsible for cartilage degradation.' If this were so, one would predict that the quantity of activePML lysosomal enzymes in synovial fluid would correlate with the degree of joint destruction. In a recent study2 we have tested this corollary hypothesis. By 9 immunochemical and enzymatic assays we quantitated 5 different granulocytic enzymes in synovial fluids from 36 patients. We are sampling a single point in time in a spectrum of disease with considerable chronicity and variability. Nonetheless a population of this size allows us to test a null hypothesis (an absence of correlation between the quantity of enzymes and the degree of radiographic destruction of the joint sampled) with some confidence. We were able to reject this null hypothesisbut the correlation we observed was negative. In other words, the greater the quantity of enzymes we detected, the less likely was the fluid sampled from a radiographically damaged joint.
This unexpected result raises 2 important questions: Since human lysosomal enzymes have the potential to participate in cartilage destruction,37 why are the enzymes in the fluid effete? And granted these enzymes are effete, why are they inversely related to destruction rather than simply unrelated? This second question provides impetus to considerable speculation. However, one potential answer to the first question is quite apparent: protease inhibitors present in the same fluids render the enzymes ineffective. Testing this hypothesis is the subject of the current report.
Normal human plasma contains at least 9 inhibitors of proteolytic enzymes 89. All Because the intention of this series of investigations is to understand the role of PML lysosomal enzymes in joint destruction, the synovial fluids were divided into inflammatory and noninflammatory fluids based solely on the absolute number of polymorphonuclear leucocytes (PML)/mm3. Inflammatory fluids have .500 PML/mm3, noninflammatory <500. There were 26 of the former and 6 of the latter.
The noninflammatory group includes fluids from 4 patients with early degenerative joint disease, 1 with systemic lupus erythematosus, and 1 with rheumatoid arthritis. The inflammatory group included 17 fluids from rheumatoid arthritis and the variants, and 7 from crystal deposition disease (5 gout, 2 CPPD). The remaining 2 inflammatory fluids were from necrotising vasculitis and systemic lupus erythematosus.
Comparison of the 2 groups (Table 3) shows the relative absence of radiographic destruction in the noninflammatory group. Unlike the results for the lysosomal enzymes,2 the inflammatory and noninflammatory groups are similar in the quantity of protease inhibitor. However, most of the clinical states represented in the noninflammatory group do not cause erosive synovitis, nor are they likely to have as many PML in synovial effusions. Since our intent is to gain some insight into the reason PML lysosomal enzymes correlate negatively with joint destruction, the noninflammatory fluids were excluded from the correlation analyses. The 7 crystal-induced inflammatory effusions did not differ significantly by any of the analyses performed on the remainder of the inflammatory fluids. The analyses presented consider all the inflammatory fluids together.
The data for the inflammatory fluids were subjected to a correlation analysis utilising a program written for the Hawlett-Packard 9830 computer equipped with a 9862 plotter. The program takes a set of data points (x,y) and calculates the coefficients of a polynomial (in this case, first degree) using a least-squares fit. Correlation coefficients (R) and R2 measure of fit are computed.
Results
Unlike the finding with lysosomal enzymes2 the quantity of several protease inhibitors reflects the total quantity of protein in the fluid (Table 4) . Since the inhibitors are synthesised principally in the liver and all except a1AT and oc1ACT exceed albumin in molecular weight,9 their presence in the synovial fluid reflects the exudative nature of the effusion. 20 The inhibitors similarly correlate with the number of PML, though not as strongly as did the lysosomal enzymes.2 However, both the lysosomal enzymes2 and the protease inhibitors (Table 4) generally correlate negatively with the degree of joint destruction observed radiographically. In spite of the fact that the protease inhibitors and lysosomal enzymes are synthesised in different sites by different cells, they are covariate in the inflammatory synovial effusions (Table 5 ). This is striking for the lysosomal enzymes LF and MPO, which were determined immunochemically and are highly covariate with the PML/ mm32 Table 1 and lysosomal enzymes in Table 2 . See Table 4 for notations of significance.
Elast-2 and CP-1 are measured enzymatically on small synthetic substrates (Table 2 ) which sacrifice specificity for high degrees of sensitivity. We previously showed that elast-2 and CP-1 values are independent of the PML/mm3, raising the possibility that they derive from a source other than the PML. These enzymatic activities are not only detectable but even correlate with the quantity of some of the inhibitors (Table 5) . Elast-2 is detectable in the presence of an inhibitor such as oc2M because the latter does not block access to the enzymes' active site by low molecular weight substrates.10 No elastase is measured if elastin is the test substrate. 2 The data in Tables 4-6 are presented as univariate correlation coefficients. This allows the reader the option of choosing his own level of confidence in suggesting the possibility that particular protease inhibitors are independent. Any such inference is testable with a larger population followed longitudinally. We believe the data do not allow one to single out any protease inhibitor as an independent variable either by inspection of the univariate correlation coefficients (Table 6) or by calculation of partial correlation coefficients. Therefore the data allows us to make the following general assertions. Protease inhibitors in inflammatory synovial effusions correlate with the total protein and PML/mm3 (Table 4 ) and with the lysosomal enzymes ( Table 5 ). As we previouslyobservedforthelysosomal enzymes,2 the quantity of these protease inhibitors is inversely related to the degree of articular destruction (Table 4) . There is no a-priori reason for the negative correlation between joint destruction and protease inhibitors (Table 4) and between joint destruction and PML lysosomal enzymes2 in the synovial fluid. This implies more than the inference that these moieties are irrelevant to joint destruction-they are relevant but not in the way one might predict. We have observed a negative correlation between C3 determined immunochemically in the effusions and joint destruction2 but a positive correlation with some protease inhibitors ( Table 4 ). It appears that there are control mechanisms modulating the several inflammatory processes in the joint in rheumatoid arthritis yet to be elucidated. inflammatory synovial effusions. 
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